QQ客服 官方微博 反馈留言

浏览/检索结果: 共31条，第1-10条 帮助 限定条件 发表日期：2019    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5 alpha-Reductase 期刊论文 SCIENTIFIC REPORTS, 2019, 卷号: 9, 页码: 10 作者:  Liu, Jiakuan;  Fang, Tian;  Li, Meiqian;  Song, Yuting;  Li, Junzun 收藏  |  浏览/下载：34/0  |  提交时间：2020/07/01 Imaging Tumorous Methylglyoxal by an Activatable Near-Infrared Fluorescent Probe for Monitoring Glyoxalase 1 Activity 期刊论文 ANALYTICAL CHEMISTRY, 2019, 卷号: 91, 期号: 24, 页码: 15577-15584 作者:  Ding, Chunyong;  Wang, Fengyang;  Dang, Yijing;  Xu, Zhiai;  Li, Lingling 收藏  |  浏览/下载：18/0  |  提交时间：2020/07/01 Neuroprotective Effect of Natural Alkaloid Fangchinoline Against Oxidative Glutamate Toxicity: Involvement of Keap1-Nrf2 Axis Regulation 期刊论文 CELLULAR AND MOLECULAR NEUROBIOLOGY, 2019, 卷号: 39, 期号: 8, 页码: 1177-1186 作者:  Bao, Fengxia;  Tao, Lingxue;  Zhang, Haiyan 收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01 Fangchinoline  Keap1  Nrf2  Oxidative stress   USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells 期刊论文 CANCER MEDICINE, 2019, 卷号: 8, 期号: 15, 页码: 6730-6740 作者:  Lu, Qin;  Zhang, Fang-Lin;  Lu, Da-Yun;  Shao, Zhi-Ming;  Li, Da-Qiang 收藏  |  浏览/下载：24/0  |  提交时间：2020/07/01 BRCA1  breast cancer  deubiquitinase  PARP inhibitor  USP9X   Lycodine-type alkaloids from Lycopodiastrum casuarinoides and their acetylcholinesterase inhibitory activity 期刊论文 FITOTERAPIA, 2019, 卷号: 139, 页码: 7 作者:  Feng, Zheling;  Chen, Shixin;  Wang, Wei;  Feng, Lu;  Dong, Yanyan 收藏  |  浏览/下载：25/0  |  提交时间：2020/07/01 Lycopodiastrum casuarinoides  Lycopodiaceae  Lycodine-type alkaloids  TD-DFT  ECD   Design, synthesis and biological evaluation of 6-deoxy O-spiroketal C-arylglucosides as novel renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 180, 页码: 398-416 作者:  Wang, Yibing;  Lou, Yang;  Wang, Jiang;  Li, Dan;  Chen, Hui 收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01 SGLT2 inhibitors  Diabetes  Sugar modification  Structure-activity relationship  Urinary glucose excretion  Oral glucose tolerance   DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism 期刊论文 EPIGENETICS & CHROMATIN, 2019, 卷号: 12, 期号: 1, 页码: 22 作者:  Chen, Ling;  Shi, Ying;  Liu, Na;  Wang, Zuli;  Yang, Rui 收藏  |  浏览/下载：24/0  |  提交时间：2020/07/01 LSH  P53  DUB  PKM2  Lipid metabolism   NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel 期刊论文 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 138, 页码: 8 作者:  Xu, Jian;  Ren, Xiaohong;  Guo, Tao;  Sun, Xian;  Chen, Xiaojin 收藏  |  浏览/下载：8/0  |  提交时间：2020/07/01 Cyclodextrins  NLG919  Solubility enhancement  Paclitaxel  IDO-1 combination immunochemotherapy   Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 178, 页码: 782-801 作者:  Wang, Jubo;  Li, Tinghan;  Zhao, Tengteng;  Wu, Tizhi;  Liu, Chuang 收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01 Wogonin  CDK9  AML  Flavonoid  Antitumor   SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met 期刊论文 CANCER SCIENCE, 2019, 页码: 11 作者:  Tong, Mengya;  Gao, Mingzhao;  Xu, Yongping;  Fu, Li;  Li, Yun 收藏  |  浏览/下载：22/0  |  提交时间：2020/07/01 AZD9291  c-Met ADC  c-Met overexpression  resistance  SHR-A1403